GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice

Схожие документы

• Acute Central Neuropeptide Y Administration Increases Food Intake but Does Not Affect Hepatic Very Low-Density Lipoprotein (Vldl) Production in Mice
  по: Geerling, Janine J., et al.
  Опубликовано: (2013)
• Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice
  по: van Diepen, Janna A., et al.
  Опубликовано: (2011)
• GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance
  по: Taher, Jennifer, et al.
  Опубликовано: (2014)
• Intracerebroventricular Administration of Neuropeptide Y Induces Hepatic Insulin Resistance via Sympathetic Innervation
  по: van den Hoek, Anita M., et al.
  Опубликовано: (2008)
• Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol
  по: Hodson, Leanne, et al.
  Опубликовано: (2020)